Showing 6071-6080 of 7669 results for "".
Understanding the Cosmetic Patient
https://practicaldermatology.com/topics/practice-management/understanding-the-cosmetic-patient/18785/Laurie Hurt, Marketing Director for Cosmetic Surgery and Dermatology at CareCredit, shares insights on the research and buying habits of cosmetic surgery patients gleaned from The Path to Purchase Study.Laser Advice for Early Adopters
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-advice-for-early-adopters/18809/“Fat melting is not a passing phase,” says Amy Forman Taub, MD. The technology is in its infancy, but applications will expand, she says. Dr. Taub, a laser and device expert offers suggestions on evaluating and choosing devices for a cosmetic practice. Generations2015 Fourth Quarter Tax Saving Tips
https://practicaldermatology.com/topics/practice-management/2015-fourth-quarter-tax-saving-tips/21088/What to do now to save $10,000-$25,000 or more on your 2015 taxes.Navigating Organizational Politics
https://practicaldermatology.com/topics/practice-management/navigating-organizational-politics/18854/Seemal Desai, MD offer tips for navigating and managing organizational politics to avoid career missteps. He also shares strategies for influencing others to help accomplish your goals in your professional and personal life.Strategies to Optimize Your Dermatology Website for Bing Search
https://practicaldermatology.com/topics/practice-management/strategies-to-optimize-your-dermatology-website-for-bing-search/21125/Despite Google's dominance in the business of online searching, Microsoft's Bing is an important search engine.Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oAdvocacy Groups and Physicians: The New Power Couple
https://practicaldermatology.com/topics/practice-management/advocacy-groups-and-physicians-the-new-power-couple/21191/Patient advocacy organizations partnering with dermatology physician-scientists offer an exciting new model for optimized patient care.Pipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigRecently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/21276/The nine reasons physician-investors underperform without professional management.